Pitcairn Co. Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pitcairn Co. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,905 shares of the medical equipment provider’s stock after selling 873 shares during the quarter. Intuitive Surgical comprises 0.6% of Pitcairn Co.’s investment portfolio, making the stock its 25th biggest position. Pitcairn Co.’s holdings in Intuitive Surgical were worth $9,346,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of ISRG. Howard Capital Management Group LLC grew its holdings in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares in the last quarter. Principal Financial Group Inc. lifted its position in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after purchasing an additional 9,194 shares during the last quarter. Benjamin Edwards Inc. grew its stake in Intuitive Surgical by 148.7% in the 3rd quarter. Benjamin Edwards Inc. now owns 13,673 shares of the medical equipment provider’s stock worth $6,718,000 after buying an additional 8,176 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Janus Henderson Group PLC now owns 689,939 shares of the medical equipment provider’s stock worth $338,948,000 after buying an additional 9,727 shares during the last quarter. Finally, Integrated Wealth Concepts LLC raised its position in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 4,821 shares of the medical equipment provider’s stock valued at $2,369,000 after buying an additional 90 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $507.05 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $180.60 billion, a P/E ratio of 79.10, a P/E/G ratio of 5.85 and a beta of 1.43. The business’s 50 day moving average price is $550.11 and its 200-day moving average price is $532.84.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial cut their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.